Choose language
< Return to main menu

WuXi Chemistry

End-to-End CRDMO Platform for Synthetic Molecules

WuXi STA

Integrated CMC Platform from Preclinical to Commercial

About Us

WuXi Chemistry, a business division of WuXi AppTec, provides contract services for new drug development from discovery to commercial.  Our unique CRDMO model offers an integrated solution combining traditional CRO (contract research organization), CDMO (contract development and manufacturing organization) and CMO (contract manufacturing organization) services under one roof.

As a world leading chemistry service organization, WuXi Chemistry have over 18,000 employees from our 15 research, development or manufacturing sites worldwide, serving over 1,800 clients from top pharma to virtual biotech companies.  Our services cover all categories for all synthetic molecular modalities, meeting any material requirement at any scale.

进程.png